"The effect of exacerbation history on outcomes in the IMPACT trial." David M.G. Halpin, Mark T. Dransfield, MeiLan K. Han, C. Elaine Jones, Sally Kilbride, Peter Lange, David A. Lipson, David A. Lomas, Fernando J. Martinez, Steve Pascoe, Dave Singh, Robert Wise and Gerard J. Criner. Eur Respir J 2020; 55: 1901921

“既往急性加重史对 IMPACT 试验结果的影响。” David MG Halpin、Mark T. Dransfield、MeiLan K. Han、C. Elaine Jones、Sally Kilbride、Peter Lange、David A. Lipson、David A. Lomas、Fernando J. Martinez、Steve Pascoe、Dave Singh、Robert Wise 和 Gerard J. Criner。《欧洲呼吸杂志》2020;55:1901921

阅读:1

Abstract

In the paragraph of the Methods section relating to patients, the range of values for the COPD Assessment Test scores was erroneously reported to be 0–400, and not the correct 0–40. The relevant sentence should correctly state:

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。